NEXI (NexImmune) OCF Margin %: 0.00% (As of Jun. 2024)


What is NexImmune OCF Margin %?

NexImmune NEXI OCF Margin % is 0.00% as of Jun. 2024.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. NexImmune's Cash Flow from Operations for the three months ended in Jun. 2024 was $-2.07 Mil. NexImmune's Revenue for the three months ended in Jun. 2024 was $0.00 Mil. Therefore, NexImmune's OCF Margin % for the quarter that ended in Jun. 2024 was 0.00%.

As of today, NexImmune's current OCF Yield % is -1,557,300.00%.

The historical rank and industry rank for NexImmune's OCF Margin % or its related term are showing as below:


NEXI's OCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -68.59
* Ranked among companies with meaningful OCF Margin % only.

NexImmune OCF Margin % Related Terms

NexImmune OCF Margin % Historical Data

* Premium members only.

The historical data trend for NexImmune's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NexImmune OCF Margin % Chart

NexImmune Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
OCF Margin %
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

NexImmune Quarterly Data
Dec18 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

NexImmune OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

NexImmune's OCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-31.43/0
= %

NexImmune's OCF Margin for the quarter that ended in Jun. 2024 is calculated as

OCF Margin=Cash Flow from Operations (Q: Jun. 2024 )/Revenue (Q: Jun. 2024 )
=-2.072/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 0.00% mean?
NexImmune (NEXI) has a OCF Margin % of 0.00% as of Jun. 2024. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on NexImmune and its competitors.
Is NexImmune's OCF Margin % too high?
NexImmune's current OCF Margin % is 0.00%.
How does NexImmune's OCF Margin % compare to PPCBD and ENDV?
NexImmune's OCF Margin % of 0.00% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on NexImmune and its competitors. NexImmune's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NexImmune stock overvalued right now?
NexImmune (NEXI) has a current OCF Margin % of 0.00%. The current OCF Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For NexImmune (NEXI), the current OCF Margin % is 0.00% as of Jun. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

NexImmune Business Description

Address 9119 Gaither Road, Gaithersburg, MD, USA, 20877
NexImmune Inc is a clinical-stage biotechnology company developing a novel approach to immunotherapy designed to employ the body's T cells to generate an antigen-specific cell-mediated immune response with curative potential for the patient. It creates therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases. The company has two product candidates in human trials: NEXI-001 in acute myeloid leukemia, or AML, and NEXI-002 in multiple myeloma, or MM.